Showing results (311-320 of 480) with videos related to
Sort By:
Pageof 48
The British Journal of Nutrition|April 13, 2018
A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patientsAmirsalar Samkani, Mads J Skytte, Daniel Kandel, et al.British Journal of Pharmacology|March 22, 2021
Short-chain fatty acids and bile acids in human faeces are associated with the intestinal cholesterol conversion statusSilke Matysik, Sabrina Krautbauer, Gerhard Liebisch, et al.Frontiers in Nutrition|August 21, 2023
Predicting weight loss success on a new Nordic diet: an untargeted multi-platform metabolomics and machine learning approachKristina Pigsborg, Valdemar Stentoft-Larsen, Samuel Demharter, et al.Journal of Lipid Research|July 29, 2011
Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in womenNathalie T Bendsen, Steen Stender, Pal B Szecsi, et al.Molecular Nutrition & Food Research|September 30, 2011
Mechanisms of weight maintenance under high- and low-protein, low-glycaemic index dietsIsabel Rubio-Aliaga, Laure F Marvin-Guy, Ping Wang, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2020
Sagittal abdominal diameter and waist circumference appear to be equally good as identifiers of cardiometabolic riskGrith Møller, Christian Ritz, Louise Kjølbæk, et al.Plos Computational Biology|March 31, 2021
Personalized computational model quantifies heterogeneity in postprandial responses to oral glucose challengeBalázs Erdős, Bart van Sloun, Michiel E Adriaens, et al.Diabetes, Obesity & Metabolism|September 13, 2021
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight lossSean Wharton, Salvatore Calanna, Melanie Davies, et al.Lancet (London, England)|March 5, 2021
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trialMelanie Davies, Louise Færch, Ole K Jeppesen, et al.Nutrients|October 23, 2021
Dietary Saturated Fats and Health: Are the U.S. Guidelines Evidence-Based?Arne Astrup, Nina Teicholz, Faidon Magkos, et al.Pageof 48